High prevalence of occult hepatitis B virus infection in Taiwanese intravenous drug users

Journal of Medical Virology

Volumn 79, Issue 11, 2007, Pages 1674-1678

  Lin, Chih ^a   Liu, Chun Jen ^b   Chen, Pei Jer ^b   Lai, Ming Yang ^b   Chen, Ding Shinn ^b   Kao, Jia Horng ^b,c  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

HBV DNA; HBV genotype; Intravenous drug user; Occult hepatitis B virus infection

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; GENOTYPE; HEPATITIS B; HEPATITIS C; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PREVALENCE; TAIWAN; VIRUS LOAD;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 84984559255     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20985     Document Type: Article

References (29)

1. Brechot C, Degos F, Lugassy C, Thiers V, Zafrani S, Franco D, Bismuth H, Trepo C, Benhamou JP, Wands J. 1985. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med 312:270-276.
2. Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain JP, Letowska M. 2006. Polish Blood Transfusion Service Viral Study Group. Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT. Hepatology 44:1666-1674.
3. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC. 1990. Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325-329.
4. Chen BF, Chen PJ, Jow GM, Liu CJ, Kao JH, Chen DS. 2004. High prevalence of mixed genotype infections in hepatitis B virus infected intravenous drug users. J Med Virol 74:536-542.
5. Chen BF, Kao JH, Liu CJ, Chen DS, Chen PJ. 2004. Genotypic dominance and novel recombinations in HBV genotype B and C coinfected intravenous drug users. J Med Virol 73:13-22.
6. Chiou HL, Lee TS, Kuo J, Mau YC, Ho MS. 1997. Altered antigenicity of 'a' determinant variants of hepatitis B virus. J Gen Virol 78:2639-2645.
7. Conjeevaram HS, Lok AS. 2001. Occult hepatitis B virus infection: A hidden menace? Hepatology 34:204-206.
8. Datta S, Banerjee A, Chandra PK, Mahapatra PK, Chakrabarti S, Chakravarty R. 2006. Drug trafficking routes and hepatitis B in injection drug users, Manipur, India. Emerg Infect Dis 12:1954-1957.
9. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. 1996. Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 86:655-661.
10. Hou J, Wang Z, Cheng J, Lin Y, Lau GK, Sun J, Zhou F, Waters J, Karayiannis P, Luo K. 2001. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology 34:1027-1034.
11. Kao JH, Chen PJ, Lai MY, Chen DS. 2001. Acute exacerbations of chronic hepatitis B are rarely associated with superinfection of hepatitis B virus. Hepatology 34:817-823.
12. Kao JH, Chen PJ, Lai MY, Chen DS. 2002. Hepatitis D virus genotypes in intravenous drug users in Taiwan: Decreasing prevalence and lack of correlation with hepatitis B virus genotypes. J Clin Microbiol 40:3047-3049.
13. Kao JH, Chen PJ, Lai MY, Chen DS. 2002. Sequence analysis of pre-S/surface and pre-core/core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection. J Med Virol 68:216-220.
14. Kao JH, Chen PJ, Lai MY, Chen DS. 2002. Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C. J Clin Microbiol 40:4068-4071.
15. Kreutz C. 2002. Molecular, immunological and clinical properties of mutated hepatitis B viruses. J Cell Mol Med 6:113-143.
16. Liu CJ, Chen DS, Chen PJ. 2006. Epidemiology of HBV infection in Asian blood donors: Emphasis on occult HBV infection and the role of NAT. J Clin Virol 36:S33-S44.
17. Liu CJ, Lo SC, Kao JH, Tseng PT, Lai MY, Ni YH, Yeh SH, Chen PJ, Chen DS. 2006. Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan. J Hepatol 44:39-46.
18. Ngui SL, Teo CG. 1997. Hepatitis B virus genomic heterogeneity: Variation between quasispecies may confound molecular epidemiological analyses of transmission incidents. J Viral Hepat 4:309-315.
19. Pollicino T, Raffa G, Costantino L, Lisa A, Campello C, Squadrito G, Levrero M, Raimondo G. 2007. Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology 45:277-285.
20. Raimondo G, Pollicino T, Cacciola I, Squadrito G. 2007. Occult hepatitis B virus infection. J Hepatol 46:160-170.
21. Song BC, Kim SH, Kim H, Ying YH, Kim HJ, Kim YJ, Yoon JH, Lee HS, Cha CY, Kook YH, Kim BJ. 2005. Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically. J Med Virol 76:194-202.
22. Spronk AM, Nelson KE. 1995. Seroepidemiology of hepatitis B virus in a population of injection drug users: Association with drug injection patterns. Am J Epidemiol 142:331-341.
23. Tabor E. 2006. Infections by hepatitis B surface antigen gene mutants in Europe and North America. J Med Virol 78:S43-S47.
24. Toan NL, Song le H, Kremsner PG, Duy DN, Binh VQ, Koeberlein B, Kaiser S, Kandolf R, Torresi J, Bock CT. 2006. Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam. Hepatology 43:1375-1384.
25. Torbenson M, Kannangai R, Astemborski J, Strathdee SA, Vlahov D, Thomas DL. 2004. High prevalence of occult hepatitis B in Baltimore injection drug users. Hepatology 39:51-57.
26. Weber B. 2005. Genetic variability of the S gene of hepatitis B virus: Clinical and diagnostic impact. J Clin Virol 32:102-112.
27. Weissenbacher M, Rossi D, Radulich G, Sosa-Estani S, Vila M, Vivas E, Avila MM, Cuchi P, Rey J, Peralta LM. 2003. High seroprevalence of bloodborne viruses among street-recruited injection drug users from Buenos Aires. Argentina Clin Infect Dis 37:S348-S352.
28. Yeh SH, Tsai CY, Kao JH, Liu CJ, Kuo TJ, Lin MW, Huang WL, Lu SF, Jih J, Chen DS, Chen PJ. 2004. Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis. J Hepatol 41:659-666.
29. Zeldis JB, Jain S, Kuramoto IK, Richards C, Sazama K, Samuels S, Holland PV, Flynn N. 1992. Seroepidemiology of viral infections among intravenous drug users in Northern California. West J Med 156:30-35.